The term “rheumatism” covers many different conditions—some of which do primarily affect older adults. Giant Cell Arteritis usually occurs after the age of 50, especially in women over 70. However, it is a serious autoimmune disease—not merely a normal sign of aging.

Direct inheritance of Giant Cell Arteritis (GCA) is very unlikely. While there appears to be a genetic predisposition, children of affected individuals do not have a significantly increased risk. Unlike classic hereditary diseases, GCA results from a combination of factors, including age, immune system responses, and environmental influences.

Yes. Giant Cell Arteritis (GCA) is linked to a higher risk of vascular complications like aneurysms or circulatory disorders. Long-term corticosteroid treatment may also cause side effects like osteoporosis or diabetes. Regular medical check-ups are important to detect and manage these secondary conditions early.

Treatment for Giant Cell Arteritis (GCA) usually lasts many months, often several years. The goal is to achieve stable remission—a state without symptoms or inflammation. While a complete cure is rare, many patients can live symptom-free long term with appropriate therapy.

A relapse of Giant Cell Arteritis (GCA) may show as new or worsening headaches, visual disturbances, or elevated inflammatory markers in the blood. General fatigue or jaw pain while chewing can also be warning signs. If a relapse is suspected, medical advice should be sought immediately—early evaluation helps prevent complications.

If you are receiving a medication from Celltrion as part of your treatment, you can log in using the batch number on the outer packaging. After logging in, you will gain access to additional information on living with a chronic inflammatory disease, including contacts for support groups and physicians, practical everyday tips, recipe ideas, and exercise routines to promote mobility. (Login)

Even if symptoms improve, do not stop taking your medication on your own. Inflammation may still be active in your body, even without noticeable symptoms. Whether a dose reduction or discontinuation is possible can only be reliably decided through regular blood tests and imaging. Always discuss any changes with your treating physician.